Healthcare Startup Olive AI Receives $51M From General Catalyst

Olive, an AI workforce of healthcare startups, has received $51 million funding from Technology venture capital firm General Catalyst. Besides, premiere venture Oak HC/FT, capital market company Ascension Ventures and Venture Capital company Drive Capital also took part in the funding round.

With the latest investment, Olive AI will expand its healthcare business. It aims to give the best healthcare service so the hospital workers could focus more on services such as cost-effective care and top-quality delivery.

In 2012, Sean Lane founded Olive AI. It creates artificial intelligence and RPA solutions that help all the health organizations to enhance their services for patient care. 

Olive AI is trying to add a new member to the AI team named “Ron Paulus”. He is a past President and CEO of Mission Health and President and CEO of RAPMD strategic advisor. Currently, he is an executive in residence at General Catalyst. As per the strategy, Olive AI is planning to collaborate with software startups with well-experienced executives to expand their healthcare business in the market.   

Olive AI uses the EHR-agnostic, and as a digital employee, it can also allot different tasks and provide every update to a manager.

Currently, Olive’s AI has been used by more than 500 hospitals in 41 states, which also includes some of the large healthcare systems OhioHealth and Centura Health.

Sean said that he has noticed, most of the technology systems of healthcare services are often disconnected from each other for learning.  

Sean said, Olive AI is here, and the days are over when bots used to disconnect themselves as they don't want to learn from others. With the latest investment, we can now help anyone through our healthcare services. We are on a mission to change the way people see healthcare and AI systems. Besides, it is focusing more on reducing the cost of healthcare and trying to improve the quality and quantity of people's lives.